These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
663 related articles for article (PubMed ID: 32525031)
1. Management of Ground-Glass Opacities in the Lung Cancer Spectrum. Zhang Y; Fu F; Chen H Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031 [TBL] [Abstract][Full Text] [Related]
2. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma. Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity. Wang Y; Jing L; Wang G J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020 [TBL] [Abstract][Full Text] [Related]
4. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma. Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094 [TBL] [Abstract][Full Text] [Related]
5. Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy. Zhang Y; Deng C; Ma X; Gao Z; Wang S; Zheng Q; Xia G; Wen Z; Han H; Fu F; Liu Q; Hu H; Li Y; Wong KK; Chen H J Cancer Res Clin Oncol; 2020 Sep; 146(9):2411-2417. PubMed ID: 32356178 [TBL] [Abstract][Full Text] [Related]
6. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma? Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638 [TBL] [Abstract][Full Text] [Related]
7. Subsolid Lesions Exceeding 3 Centimeters: The Ground-Glass Opacity Component Still Matters. Fan F; Zhang Y; Fu F; Gao Z; Zhao Y; Han H; Lai J; Wen Z; Ma X; Deng C; Ma Z; Wang S; Deng L; Li Y; Ye T; Chen H Ann Thorac Surg; 2022 Mar; 113(3):984-992. PubMed ID: 33839135 [TBL] [Abstract][Full Text] [Related]
8. Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma. Sun F; Huang Y; Yang X; Zhan C; Xi J; Lin Z; Shi Y; Jiang W; Wang Q Cancer Imaging; 2020 Dec; 20(1):87. PubMed ID: 33308323 [TBL] [Abstract][Full Text] [Related]
9. Pregnancy may have little influence on ground-glass opacities suspected for lung adenocarcinoma. Bai J; Deng C; Fu F; Li D; Ma Z; Ma X; Zhang Y; Chen H J Cancer Res Clin Oncol; 2023 Apr; 149(4):1383-1389. PubMed ID: 35445333 [TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of tumour spread through air space in radiological subsolid and pure solid lung adenocarcinoma. Zhong Y; Xu Y; Deng J; Wang T; Sun X; Chen D; Wu C; Hou L; Xie H; She Y; Xie D; Chen C Eur J Cardiothorac Surg; 2021 Apr; 59(3):624-632. PubMed ID: 33188689 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features and lymph node metastatic characteristics in patients with adenocarcinoma manifesting as part-solid nodule exceeding 3 cm in diameter. Li W; Zhou F; Wan Z; Li M; Zhang Y; Bao X; Zhang L; Shi J Lung Cancer; 2019 Oct; 136():37-44. PubMed ID: 31437662 [TBL] [Abstract][Full Text] [Related]
12. Ground-glass opacity lesions on computed tomography during postoperative surveillance for primary non-small cell lung cancer. Haro A; Yano T; Kohno M; Yoshida T; Okamoto T; Maehara Y Lung Cancer; 2012 Apr; 76(1):56-60. PubMed ID: 21945659 [TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of solid component for lung adenocarcinoma shown as ground-glass nodule on computed tomography]. Ge X; Gao F; Li M; Chen Y; Lü F; Ren Q; Hua Y Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):1010-3. PubMed ID: 24851690 [TBL] [Abstract][Full Text] [Related]
14. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma. Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010 [TBL] [Abstract][Full Text] [Related]
15. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity. Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278 [TBL] [Abstract][Full Text] [Related]
16. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Asamura H; Suzuki K; Watanabe S; Matsuno Y; Maeshima A; Tsuchiya R Ann Thorac Surg; 2003 Oct; 76(4):1016-22. PubMed ID: 14529977 [TBL] [Abstract][Full Text] [Related]
17. Different clinicopathological features between young and older patients with pulmonary adenocarcinoma and ground-glass opacity. Lu X; Chen Y; Li Y; Tang M; Zheng X Sci Rep; 2024 Jul; 14(1):15679. PubMed ID: 38977890 [TBL] [Abstract][Full Text] [Related]
18. Predictors of Pathologic Tumor Invasion and Prognosis for Ground Glass Opacity Featured Lung Adenocarcinoma. Ye T; Deng L; Xiang J; Zhang Y; Hu H; Sun Y; Li Y; Shen L; Wang S; Xie L; Chen H Ann Thorac Surg; 2018 Dec; 106(6):1682-1690. PubMed ID: 30096292 [TBL] [Abstract][Full Text] [Related]
19. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications. Lee HY; Lee KS J Thorac Imaging; 2011 May; 26(2):106-18. PubMed ID: 21508733 [TBL] [Abstract][Full Text] [Related]
20. HRCT features between lepidic-predominant type and other pathological subtypes in early-stage invasive pulmonary adenocarcinoma appearing as a ground-glass nodule. Zhang P; Li T; Tao X; Jin X; Zhao S BMC Cancer; 2021 Oct; 21(1):1124. PubMed ID: 34666705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]